313 related articles for article (PubMed ID: 29546579)
1. The antidiabetic drug metformin blunts NETosis in vitro and reduces circulating NETosis biomarkers in vivo.
Menegazzo L; Scattolini V; Cappellari R; Bonora BM; Albiero M; Bortolozzi M; Romanato F; Ceolotto G; Vigili de Kreutzeberg S; Avogaro A; Fadini GP
Acta Diabetol; 2018 Jun; 55(6):593-601. PubMed ID: 29546579
[TBL] [Abstract][Full Text] [Related]
2. NETosis before and after Hyperglycemic Control in Type 2 Diabetes Mellitus Patients.
Carestia A; Frechtel G; Cerrone G; Linari MA; Gonzalez CD; Casais P; Schattner M
PLoS One; 2016; 11(12):e0168647. PubMed ID: 28005949
[TBL] [Abstract][Full Text] [Related]
3. NETosis is induced by high glucose and associated with type 2 diabetes.
Menegazzo L; Ciciliot S; Poncina N; Mazzucato M; Persano M; Bonora B; Albiero M; Vigili de Kreutzenberg S; Avogaro A; Fadini GP
Acta Diabetol; 2015 Jun; 52(3):497-503. PubMed ID: 25387570
[TBL] [Abstract][Full Text] [Related]
4. A perspective on NETosis in diabetes and cardiometabolic disorders.
Fadini GP; Menegazzo L; Scattolini V; Gintoli M; Albiero M; Avogaro A
Nutr Metab Cardiovasc Dis; 2016 Jan; 26(1):1-8. PubMed ID: 26719220
[TBL] [Abstract][Full Text] [Related]
5. Randomized, Double-Blind, Phase 3 Trial of Triple Therapy With Dapagliflozin Add-on to Saxagliptin Plus Metformin in Type 2 Diabetes.
Mathieu C; Ranetti AE; Li D; Ekholm E; Cook W; Hirshberg B; Chen H; Hansen L; Iqbal N
Diabetes Care; 2015 Nov; 38(11):2009-17. PubMed ID: 26246458
[TBL] [Abstract][Full Text] [Related]
6. Dapagliflozin improves glycemic control and reduces body weight as add-on therapy to metformin plus sulfonylurea: a 24-week randomized, double-blind clinical trial.
Matthaei S; Bowering K; Rohwedder K; Grohl A; Parikh S;
Diabetes Care; 2015 Mar; 38(3):365-72. PubMed ID: 25592197
[TBL] [Abstract][Full Text] [Related]
7.
Díaz-Godínez C; Fonseca Z; Néquiz M; Laclette JP; Rosales C; Carrero JC
Front Cell Infect Microbiol; 2018; 8():184. PubMed ID: 29922599
[TBL] [Abstract][Full Text] [Related]
8. Effect of Vitamin D3 in combination with Omega-3 Polyunsaturated Fatty Acids on NETosis in Type 2 Diabetes Mellitus Patients.
Basyreva LY; Vakhrusheva TV; Letkeman ZV; Maximov DI; Fedorova EA; Panasenko ОM; Ostrovsky EM; Gusev SA
Oxid Med Cell Longev; 2021; 2021():8089696. PubMed ID: 34721760
[TBL] [Abstract][Full Text] [Related]
9. Hydrogen sulfide primes diabetic wound to close through inhibition of NETosis.
Yang CT; Chen L; Chen WL; Li N; Chen MJ; Li X; Zheng X; Zhao YZ; Wu YX; Xian M; Liu J
Mol Cell Endocrinol; 2019 Jan; 480():74-82. PubMed ID: 30339820
[TBL] [Abstract][Full Text] [Related]
10. Serum and Serum Albumin Inhibit
Neubert E; Senger-Sander SN; Manzke VS; Busse J; Polo E; Scheidmann SEF; Schön MP; Kruss S; Erpenbeck L
Front Immunol; 2019; 10():12. PubMed ID: 30733715
[TBL] [Abstract][Full Text] [Related]
11. Dapagliflozin has no effect on markers of bone formation and resorption or bone mineral density in patients with inadequately controlled type 2 diabetes mellitus on metformin.
Ljunggren Ö; Bolinder J; Johansson L; Wilding J; Langkilde AM; Sjöström CD; Sugg J; Parikh S
Diabetes Obes Metab; 2012 Nov; 14(11):990-9. PubMed ID: 22651373
[TBL] [Abstract][Full Text] [Related]
12. Histone Acetylation Promotes Neutrophil Extracellular Trap Formation.
Hamam HJ; Khan MA; Palaniyar N
Biomolecules; 2019 Jan; 9(1):. PubMed ID: 30669408
[TBL] [Abstract][Full Text] [Related]
13. NETosis Delays Diabetic Wound Healing in Mice and Humans.
Fadini GP; Menegazzo L; Rigato M; Scattolini V; Poncina N; Bruttocao A; Ciciliot S; Mammano F; Ciubotaru CD; Brocco E; Marescotti MC; Cappellari R; Arrigoni G; Millioni R; Vigili de Kreutzenberg S; Albiero M; Avogaro A
Diabetes; 2016 Apr; 65(4):1061-71. PubMed ID: 26740598
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy for type 2 diabetes: dapagliflozin plus metformin.
Tan X; Hu J
Expert Opin Pharmacother; 2016; 17(1):117-26. PubMed ID: 26567559
[TBL] [Abstract][Full Text] [Related]
15. Diabetes primes neutrophils to undergo NETosis, which impairs wound healing.
Wong SL; Demers M; Martinod K; Gallant M; Wang Y; Goldfine AB; Kahn CR; Wagner DD
Nat Med; 2015 Jul; 21(7):815-9. PubMed ID: 26076037
[TBL] [Abstract][Full Text] [Related]
16. Elevated homocysteine levels in type 2 diabetes induce constitutive neutrophil extracellular traps.
Joshi MB; Baipadithaya G; Balakrishnan A; Hegde M; Vohra M; Ahamed R; Nagri SK; Ramachandra L; Satyamoorthy K
Sci Rep; 2016 Nov; 6():36362. PubMed ID: 27811985
[TBL] [Abstract][Full Text] [Related]
17. NETosis proceeds by cytoskeleton and endomembrane disassembly and PAD4-mediated chromatin decondensation and nuclear envelope rupture.
Thiam HR; Wong SL; Qiu R; Kittisopikul M; Vahabikashi A; Goldman AE; Goldman RD; Wagner DD; Waterman CM
Proc Natl Acad Sci U S A; 2020 Mar; 117(13):7326-7337. PubMed ID: 32170015
[TBL] [Abstract][Full Text] [Related]
18. Exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin monotherapy (DURATION-8): a 28 week, multicentre, double-blind, phase 3, randomised controlled trial.
Frías JP; Guja C; Hardy E; Ahmed A; Dong F; Öhman P; Jabbour SA
Lancet Diabetes Endocrinol; 2016 Dec; 4(12):1004-1016. PubMed ID: 27651331
[TBL] [Abstract][Full Text] [Related]
19. Effect of dapagliflozin on obstructive sleep apnea in patients with type 2 diabetes: a preliminary study.
Tang Y; Sun Q; Bai XY; Zhou YF; Zhou QL; Zhang M
Nutr Diabetes; 2019 Nov; 9(1):32. PubMed ID: 31685792
[TBL] [Abstract][Full Text] [Related]
20. The Diethylcarbamazine Delays and Decreases the NETosis of Polymorphonuclear Cells of Humans with DM Type 2.
Segoviano-Ramirez JC; Lopez-Altamirano DF; Garcia-Juarez J; Aguirre-Garza JES; Cárdenas-Estrada E; Ancer-Rodriguez J
J Diabetes Res; 2020; 2020():4827641. PubMed ID: 32190698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
